Home LiteratureArticle Details
PMID: 6134543 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.

British journal of clinical pharmacology ·Vol. 15 ·No. 5 ·1983-05-00 ·Pages 545-52

Aranko K, Mattila MJ, Seppälä T

Abstract

1 Development of tolerance and cross-tolerance to lorazepam and diazepam in man was assessed in a double-blind and cross-over trial where eight pretrained healthy students volunteered for four 1 week treatment periods started at 1 month intervals. 2 In each period acute psychomotor responses to oral lorazepam 3 mg and diazepam 15 mg were recorded on day 1, as well as on day 8 after 1 week's treatment twice daily with diazepam 5 mg, lorazepam 1 mg, and placebo. At each session several objective psychomotor tests and subjective assessments were done before the drug intake and 1, 2.5, and 4 h after it. 3 In general, the effects of lorazepam were stronger and of longer duration than those of diazepam at the doses used. When comparing the single-dose responses on days 1 and 8, tolerance to lorazepam effects and some cross-tolerance developed on several functions measured. Tolerance but not cross-tolerance developed on choice reaction errors whereas the opposite was found on flicker fusion. No definite tolerance was found on subjective effects. 4 The results tally with an assumption that tolerance to benzodiazepine actions develops at different rates on various parameters measured.

MeSH Terms
Adult Anti-Anxiety Agents/pharmacology Diazepam/pharmacology Drug Tolerance Humans Lorazepam/pharmacology Psychomotor Performance/drug effects Time Factors
Chemicals
Anti-Anxiety Agents Lorazepam Diazepam
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Aranko K
Mattila M J
Seppälä T
References (22)
22 references, click to expand
  1. Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam.
    Psychopharmacologia. 1968;13(1):74-80 PMID: 5675460
  2. Measurement of recovery from outpatient general anaesthesia with a simple ocular test.
    Br Med J. 1970 Jul 18;3(5715):132-5 PMID: 5431082
  3. Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam.
    Br J Clin Pharmacol. 1976 Oct;3(5):831-41 PMID: 9967
  4. Effect of active metabolites of chlordiazepoxide and diazepam, alone or in combination with alcohol, on psychomotor skills related to driving.
    Eur J Clin Pharmacol. 1978 Jul 30;13(5):345-50 PMID: 352710
  5. Visual analogue scales.
    Br J Clin Pharmacol. 1979 Jan;7(1):124 PMID: 760737
  6. Effects of m-xylene on human equilibrium measured with a quantitative method.
    Acta Pharmacol Toxicol (Copenh). 1979 Apr;44(4):315-8 PMID: 433626
  7. Mood and performance of poor sleepers during repeated use of flurazepam.
    Psychopharmacology (Berl). 1979 Mar 28;61(3):309-16 PMID: 36646
  8. Acute effects of temazepam and nitrazepam on psychomotor skills and memory.
    Acta Pharmacol Toxicol (Copenh). 1979 May;44(5):364-9 PMID: 38627
  9. Radiohistochemical localization of benzodiazepine receptors in rat brain.
    J Pharmacol Exp Ther. 1980 Feb;212(2):337-46 PMID: 7351647
  10. The two-period cross-over clinical trial.
    Br J Clin Pharmacol. 1979 Jul;8(1):7-20 PMID: 552299
  11. Psychomotor function and psychoactive drugs.
    Br J Clin Pharmacol. 1980 Sep;10(3):189-209 PMID: 7002180
  12. Anxiety and sedation during a stressful situation after single dose of diazepam versus N-desmethyldiazepam--a controlled trial.
    Psychopharmacology (Berl). 1980;70(3):303-5 PMID: 6777806
  13. Kinetics and neuropsychologic effects of IV diazepam in the presence and absence of its active N-desmethyl metabolite in humans.
    Psychopharmacology (Berl). 1980;70(3):307-12 PMID: 6777807
  14. Tofisopam, a novel 3,4-benzodiazepine: multiple-dose effects on psychomotor skills and memory. Comparison with diazepam and interactions with ethanol.
    Psychopharmacology (Berl). 1980;69(2):209-18 PMID: 6109345
  15. Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding.
    Eur J Pharmacol. 1981 Apr 9;70(4):453-60 PMID: 7238571
  16. Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats.
    Psychopharmacology (Berl). 1981;73(3):240-5 PMID: 6113617
  17. Chronic clonazepam administration induces benzodiazepine receptor subsensitivity.
    Neuropharmacology. 1982 Jan;21(1):85-9 PMID: 6278355
  18. Clearance of diazepam can be impaired by its major metabolite desmethyldiazepam.
    Eur J Clin Pharmacol. 1981;21(2):161-3 PMID: 6804244
  19. Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.
    J Clin Psychopharmacol. 1982 Apr;2(2):102-6 PMID: 6122694
  20. Effects of alcohol on buspirone and lorazepam actions.
    Clin Pharmacol Ther. 1982 Aug;32(2):201-7 PMID: 6124334
  21. Caffeine antagonizes diazepam effects in man.
    Med Biol. 1982 Apr;60(2):121-3 PMID: 7098543
  22. Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.
    Psychopharmacology (Berl). 1982;77(3):284-8 PMID: 6126909
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1983-05-00
Pages
545-52
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1427709
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]